BRCA2 and breast carcinoma: BRCA2-selective hypersensitivity of cancer cells towards the WRNi was further recapitulated in the breast cancer cell line MDA-MB-231 (Supplementary Fig. 10a) and ovarian cancer cell line SKOV-3 (Supplementary Fig. 10b), suggesting generality of the phenotype.